Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 11, 2025The Prostate

Impact of Testosterone Recovery on Oncologic Outcomes in High‐Risk, Localized Prostate Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

THTrevor C. HuntKMKamil MalshyMSMatthew Steidle

Discussion

Loading...

Member takes

Overview

Retrospective analysis shows testosterone recovery does not significantly affect oncologic outcomes, indicating further research is needed.

Key Points

  • No significant differences in overall survival were observed between testosterone recovery groups, highlighting treatment challenges.
  • Among 445 eligible patients, 87.2% achieved testosterone recovery, but it did not impact modified event-free survival or overall survival.
  • Retrospective analysis of two large phase III clinical trials explored testosterone recovery's role in high-risk prostate cancer outcomes.
  • Findings suggest testosterone recovery status is not significantly associated with oncologic outcomes, indicating a need for alternative strategies.

Cite This Study

Hunt et al. (2025) studied this question.

synapsesocial.com/papers/68d413ff713b0b5dfea61efchttps://doi.org/10.1002/pros.70043
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism2026 · 4 citations
  2. 2Long-term Oncological Outcomes of Neoadjuvant Androgen-deprivation Therapy Prior to Radical Prostatectomy2025
  3. 3How does Testosterone Therapy Impact Quality of Life and Cancer Recurrence Rates in High-Risk Prostate Cancer Survivors? : A Systematic Review2025
  4. 4Oncological safety of testosterone replacement therapy in men with localised prostate cancer: a systematic review of observational studies2025
  5. 5Time to Prostate‐Specific Antigen Failure as a Unique Prognosticator of Overall Survival in Biochemically Recurrent Prostate Cancer Patients Undergoing Radical Prostatectomy2025